Journals / Turkish Thoracic Journal / 2021 / Cilt: 22 - Sayı: 2

How were Non-COVID pulmonary patients and diseases affected from COVID-19 pandemic period?

Pages
149–153
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

RESULTS: In the pandemic period, it was found that there was an 84% decrease in outpatient admissions, a 43% decrease in inpatients, and a 75% decrease in emergency services.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:JECTIVE: This study aimed to focus on non-COVID-19 patients during the process when all physicians focused on COVID-19 patients.
📊
Key Findings & Data:Patients with pulmonary diseases in the COVID-19 pandemic period were analyzed.
💡
Conclusion & Impact:RESULTS: In the pandemic period, it was found that there was an 84% decrease in outpatient admissions, a 43% decrease in inpatients, and a 75% decrease in emergency services.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Özet

JECTIVE: This study aimed to focus on non-COVID-19 patients during the process when all physicians focused on COVID-19 patients. Patients with pulmonary diseases in the COVID-19 pandemic period were analyzed. MATERIAL AND METHODS: Non-COVID-19 cases who were hospitalized in the pulmonology clinic, outpatients, and patients who applied to the non-COVID-19 emergency service and requested a pulmonology consultation in the period from March 16, 2020 to May 15, 2020 and in the same period of the previous year (i.e., from March 16, 2019 to May 15, 2019) were included in this study. RESULTS: In the pandemic period, it was found that there was an 84% decrease in outpatient admissions, a 43% decrease in inpatients, and a 75% decrease in emergency services. During the pandemic period, in outpatient setting, male and younger case admissions in creased, admissions with chronic obstructive pulmonary disease (COPD), and interstitial lung diseases decreased, whereas the frequency of admission to asthma, pneumonia, and pulmonary thromboembolism increased. In the period of the pandemic, patients with asthma, COPD, and lung cancer were less hospitalized, whereas patients with pulmonary thromboembolism, pneumonia, and pleural effusion were hospitalized more. In non-COVID-19 patient treatments during the pandemic period, usage of a metered dose inhaler increased. CONCLUSION: During the COVID-19 pandemic, non-COVID pulmonary pathologies decreased significantly, and there was a change in the profile of the patients. From now on, to be prepared for pandemic and similar extraordinary situations, to organize hospitals for the epidemic, to determine health institutions to which nonepidemic patients can apply, to make necessary plans in order not to neglect the nonepidemic patients, and to develop digital health service methods, especially telemedicine, would be appropriate.

🔖

Cite This Article

SEVİNÇ, C., TERTEMİZ, K. C., ATİK, M., GÜLER, N., ULUSOY, M., COŞKUN, F., UYAR, N., ELLİDOKUZ, H., İTİL, O., CİMRİN, A. H., UÇAN, E. S. (2021). How were Non-COVID pulmonary patients and diseases affected from COVID-19 pandemic period?. Turkish Thoracic Journal, Cilt: 22 - Sayı: 2, 149–153. https://ajindex.com/articles/417917

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Baloch S, Baloch MA, Zheng T, Pei X. The coronavirus disease 2019 (COVID-19) pandemic. Tohoku J Exp Med 2020
  2. [CrossRef] 2. Majersik JJ, Reddy VK. Acute neurology during the COVID-19 pandemic: supporting the front line. Neurology 2020
  3. [CrossRef] 3. Hart JL, Turnbull AE, Oppenheim IM, Courtright KR. FamilyCentered Care During the COVID-19 Era. J Pain Symptom Manage 2020
  4. e93-e7. [CrossRef] 4. Prachand VN, Milner R, Angelos P, et al. Medically necessary, timesensitive procedures: scoring system to ethically and efficiently manage resource scarcity and provider risk during the COVID-19 pandemic. J Am Coll Surg 2020
  5. [CrossRef] 5. Kretchy IA, Asiedu-Danso M, Kretchy JP. Medication management and adherence during the COVID-19 pandemic: perspectives and experiences from low-and middle-income countries. Res Social Adm Pharm 2021
  6. [CrossRef] 6. Block BL, Smith AK, Sudore RL. During COVID-19, outpatient advance care planning is imperative: we need all hands on deck. J Am Geriatr Soc 2020
  7. [CrossRef] 7. Weller M, Preusser M. How we treat patients with brain tumour during the COVID-19 pandemic. ESMO Open 2020
  8. e000789. [CrossRef] 8. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 2020
  9. [CrossRef] 9. Mehra MR, Desai SS, Kuy SR, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in COVID-19. N Engl J Med 202
  10. e102. [CrossRef] 10. Keny S, Bagaria V, Chaudhary K, Dhawale A. Emergency and urgent orthopaedic surgeries in non-covid patients during the COVID 19 pandemic: perspective from India. J Orthop 2020
  11. [CrossRef] 11. Silverman DA, Lin C, Tamaki A, et al. Respiratory and pulmonary complications in head and neck cancer patients: evidencebased review for the COVID-19 era. Head Neck 2020
  12. [CrossRef] 12. Eke OF, Morone CC, Liteplo AS, Shokoohi H. Non-Covid-19 clinical research in the era of pandemic. Am J Emerg Med 2021
  13. [CrossRef] 13. Republic of Turkey, Ministry of Health data. 2020. Available at: https://covid19bilgi.saglik.gov.tr/tr/haberler/turkiye-deki-gunluk-covid-19-vaka-sayilari.html. 14. Elson EC, Oermann C, Duehlmeyer S, Bledsoe S. Use of telemedicine to provide clinical pharmacy services during the SARS-CoV-2 pandemic. Am J Health Syst Pharm 2020
  14. [CrossRef] 15. Ateev Mehrotra et al., “The Impact of the C